Helping a Teenager Who Vapes
Combine behavioral counseling with a trial of varenicline for adolescents who vape nicotine, as this approach achieves the highest cessation rates (51% at 3 months) with acceptable side effects. 1
Treatment Algorithm
First-Line Approach: Behavioral Counseling + Varenicline
Start with behavioral support immediately:
- Enroll the teenager in text message-based cessation programs (e.g., "This is Quitting") - these increase quit rates by 32% in youth aged 13-24 1, 2, 3
- Provide brief individual counseling sessions focused on motivation and coping strategies
- Consider multi-component school or community-based programs if available 4
Add varenicline for motivated adolescents:
- The 2025 American Thoracic Society guideline conditionally recommends varenicline for ages 10-18 who use nicotine products 1
- Dosing: Weight-based approach from clinical trials:
- If >55 kg: Start 0.5 mg daily for 3 days, then 0.5 mg twice daily for 4 days, then 1 mg twice daily (maximum 2 mg/day)
- If ≤55 kg: Use lower doses (0.5-1 mg/day total)
- Duration: 12 weeks of treatment
- Expected outcomes: 51% continuous abstinence at weeks 9-12 versus 14% with placebo alone; sustained benefit of 28% versus 7% at 6 months 1
- Side effects: Primarily gastrointestinal (nausea) with higher doses; low-dose varenicline shows no increase in adverse events 1
Second-Line Option: Bupropion
If varenicline is unavailable, not tolerated, or contraindicated:
- The ATS conditionally recommends bupropion as an alternative 1
- However, evidence is weaker - studies in adolescents showed no significant benefit over placebo for smoking cessation 1
- Dosing: 150-300 mg/day sustained-release formulation for 6 weeks
- Consider only for adolescents with moderate to severe nicotine dependence
Third-Line: Nicotine Replacement Therapy (NRT)
Use combination NRT cautiously:
- Evidence for vaping cessation is very limited and inconclusive in adolescents 2, 3
- Current data shows no clear benefit (RR 0.96,95% CI 0.73-1.25) 3
- Most guidelines support NRT for smoking cessation in youth ≥12 years, but none specifically endorse it for vaping cessation 5
- If used, combine patch + short-acting form (gum, lozenge)
Key Clinical Considerations
Assess nicotine dependence severity:
- Ask: "How soon after waking do you want to vape?"
- Wanting to vape within 30 minutes indicates higher dependence and predicts who will use cessation aids 6
- Higher dependence increases likelihood of accepting pharmacotherapy (OR 2.83) 6
Address motivation:
- Adolescents planning to quit within 12 months are nearly twice as likely to use cessation therapy (OR 1.88) 6
- Most youth who vape regret starting and want to quit 4
Monitor for tobacco smoking:
- Vaping in adolescents is associated with future cigarette smoking 1
- No current evidence shows cessation interventions increase smoking uptake 3
- Continue monitoring tobacco use throughout treatment
Important Caveats
Medication adherence strategies matter:
- The successful varenicline trial used $1 incentives for video-recorded medication administration 1
- Behavioral counseling adherence was lower in placebo groups, suggesting combined treatment improves engagement 1
Racial/ethnic disparities exist:
- Hispanic adolescents have 54% lower odds of using any cessation therapy compared to non-Hispanic White youth 6
- Proactively offer and discuss cessation options with all adolescents
Current utilization is extremely low:
- Only 10.6% of adolescents who vape report using any cessation aid 6
- NRT is most commonly used (4.4%), but medications are least used (3.3%) despite stronger evidence for varenicline 6
Safety profile:
- Most studies reported zero serious adverse events across all interventions 1, 2, 3
- The one reported SAE occurred in the varenicline group but was not clearly treatment-related 1
- Decades of smoking cessation research with these medications shows acceptable safety profiles